Chiara Russo

Dr. Chiara Russo

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
Nicolò Matteo Luca BattistiNicolò Matteo Luca Battisti
Nicolò Matteo Luca Battisti
AMAnna Rachelle Mislang
Anna Rachelle Mislang
LCLisa Cooper
Lisa Cooper
AOAnita O'Donovan
Anita O'Donovan
RARiccardo A. Audisio
Riccardo A. Audisio
HWhans wildiers
hans wildiers

1 June 2021 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
AMAnna Rachelle Mislang
Anna Rachelle Mislang
ESEnrique Soto-Pérez-De-Celis
Enrique Soto-Pérez-De-Celis
CRChiara Russo
Chiara Russo
GCGiuseppe Ferdinando Colloca
Giuseppe Ferdinando Colloca
GWGrant Williams
Grant Williams
Nicolò Matteo Luca BattistiNicolò Matteo Luca Battisti
Nicolò Matteo Luca Battisti

19 October 2021 in European Journal of Cancer Care
Verified
Journal Article
Closed access
PDF file
BFBaptiste Fournier
Baptiste Fournier
LDLidia Delrieu
Lidia Delrieu
CRChiara Russo
Chiara Russo
CTCatherine Terret
Catherine Terret
BFBéatrice Fervers
Béatrice Fervers
OPOlivia Pérol
Olivia Pérol

15 July 2022 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
ESEnrique Soto-Pérez-De-Celis
Enrique Soto-Pérez-De-Celis
AMAnna Rachelle Mislang
Anna Rachelle Mislang
CHCelia Gabriela Hernández-Favela
Celia Gabriela Hernández-Favela
CRChiara Russo
Chiara Russo
GCGiuseppe Ferdinando Colloca
Giuseppe Ferdinando Colloca
Nicolò Matteo Luca BattistiNicolò Matteo Luca Battisti
Nicolò Matteo Luca Battisti

15 April 2021 in Geriatrics
Verified
Journal Article
Open access
PDF file
ATAntonino C Tralongo
Antonino C Tralongo
RFRoberto S. Fratamico
Roberto S. Fratamico
CRChiara Russo
Chiara Russo
ASAndrea Sbrana
Andrea Sbrana
AAAndrea Antonuzzo
Andrea Antonuzzo
MDMarco Danova
Marco Danova
Aging is a well-recognized risk factor for the development of cancer. The incidence of new cancer diagnoses has increased globally given the rising senior population. Many hypotheses for this increased risk have been postulated over decades, including increased genetic and epigenetic mutations and the concept of immunosenescence. The optimal treatment strategies for this population with cancer are unclear. Older cancer patients are traditionally under-represented in clinical trials developed to set the standard of care, leading to undertreatment or increased toxicity. With this background, it is crucial to investigate new opportunities that belong to the most recent findings of an anti-cancer agent, such as immune-checkpoint inhibitors, to manage these daily clinical issues and eventually combine them with alternative administration strategies of antiblastic drugs such as metronomic chemotherapy.

16 August 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
Dominique TremblayDominique Tremblay
Dominique Tremblay
CRChiara Russo
Chiara Russo
CTCatherine Terret
Catherine Terret
CPCatherine Prady
Catherine Prady
SJSonia Joannette
Sonia Joannette
NMNathalie Moreau
Nathalie Moreau
The growing number of older adults with cancer confront practical and organizational limitations that hinder their ability to obtain care that is adapted to their health status, needs, expectations, and life choices. The integration into practice of evidence-based and institutional recommendations for a geriatric approach and person-centered high-quality care remains incomplete. This study uses an action research design to explore stakeholders’ perspectives of the challenges involved in translating the established care priorities into a compassionate geriatric approach in oncology and identify promising pathways to improvement. Fifty-three stakeholders participated in focus groups to create cognitive maps representing perceived relationships between concepts related to compassionate care of older adults with cancer. Combining maps results in a single model constructed in Mental Modeler software to weigh relationships and calculate concept centrality (importance in the model). The model represents stakeholders’ collective perspective of the determinants of compassionate care that need to be addressed at different decision-making levels. The results reveal pathways to improvement at systemic, organizational, practice, and societal levels. These include connecting policies on ageing and national cancer programs, addressing fragmented care through interdisciplinary teamwork, promoting person-centered care, cultivating relational proximity, and combatting ageism. Translating evidence-based practices and priority orientations into compassionate care rests on collective capacities across multiple providers to address the whole person and their unique trajectory.